| NYHA | New York Heart Association Heart Disease에 대한 Functional Classification &nbs... |
|---|---|
| WDMF | wall-defective microbial forms |
| ad | add [Lat. adde] let there be added [up to a specified amount] [Lat. addetur]; axiodistal; right ear ... |
| ET | educational therapy; effective temperature; ejection time; embryo transfer; endothelin; endotoxin; e... |
| IT | immunological test; immunotherapy; implantation test; individual therapy; information technology; in... |
| ET | Essential Tremor |
|---|---|
| OT | Orthostatic tremor |
| pt | Paralytic tremor |
| EDNOS | Eating Disorder Not Otherwise Specified |
| NOS | Not Otherwise Specified |
intentional replantation
| other-directed | Pertaining to a person readily influenced by the attitudes of others. (05 Mar 2000) |
|---|---|
| transferases (other substituted phosphate groups) | <enzyme> A class of enzymes that transfers substituted phosphate groups. Registry number: EC 2.7.8 (12 Dec 1998) |
| accole forms | A term applied to the manner in which the ring stage of Plasmodium falciparum parasitises the marginal portion of erythrocytes. Synonym: accole forms. (05 Mar 2000) |
| applique forms | A term applied to the manner in which the ring stage of Plasmodium falciparum parasitises the marginal portion of erythrocytes. Synonym: accole forms. (05 Mar 2000) |
| atypical bacterial forms | Microorganisms that have undergone greater changes than normal in morphology, physiology, or cultural characteristics. (12 Dec 1998) |
| dosage forms | Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect. They include capsules, liniments, ointments, pharmaceutical solutions, powders, tablets, etc. (12 Dec 1998) |
| forms and records control | A management function in which standards and guidelines are developed for the developing, maintaining, and handling of forms and records. (12 Dec 1998) |
| forms of DNA i, II and III | Refers to circular DNA removed from viruses and as plasmids. Form I is the DNA in its normal, supercoiled form. Form II is the DNA after one of the two strands has been nicked (cut apart), and is circular. Form III is the DNA after both strands have been broken, and is linear. (09 Oct 1997) |
| l forms | Bacterial variants, unable to form a complete cell wall, which are formed in cultures by various bacteria; granules (l bodies) appear, unite, and grow into amorphous bodies which multiply and give rise to bacterial cells morphologically indistinguishable from the parent strain. (12 Dec 1998) |
| action tremor | <neurology> A tremor which arises or which is intensified when a voluntary, coordinated movement is attempted. (18 Nov 1997) |
| alcoholic withdrawal tremor | Intention tremor present in the withdrawal period of one of two types: 1) a tremor of greater than 8 Hz, with continuous antagonistic muscle activity, and 2) a tremor of less than 8 Hz, with intermittent spontaneous antagonistic muscle activity. (05 Mar 2000) |
| alternating tremor | A form of hyperkinesia characterised by regular, symmetrical, to-and-fro movements (at about 4 per second) that are produced by patterned, alternating contraction of muscles and their antagonists. (05 Mar 2000) |
| alternative tremor | A coarse, low frequency (3-8 Hz) pathologic tremor produced by alternating contraction of muscles and their antagonists; seen with Parkinson disease and kinetic predominant action tremor. (05 Mar 2000) |
| arsenical tremor | A tremor caused by chronic poisoning by arsenic. (05 Mar 2000) |
| ataxic tremor | <neurology> A tremor which arises or which is intensified when a voluntary, coordinated movement is attempted. (18 Nov 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|